Clinical Trials Browser

Phase 1 × Clofarabine × Other solid neoplasm × Clear all

NCT00125827 2014-03-19

Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors